Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: Favorable response to rituximab

Anatoly Nemets, Meir Ronen, Gilles Lugassy

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Mantle cell lymphoma (MCL) is an aggressive type of malignant lymphoma with short median survival despite conventional therapy. We describe the unusual case of a 66-year-old man with a chronic skin rash which preceded the occurrence of an indolent MCL by 2 years. Repeated skin biopsies did not show involvement by the lymphoma. Short therapy with rituximab resulted in the complete and lasting resolution of the cutaneous lesions.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalActa Haematologica
Volume115
Issue number1-2
DOIs
StatePublished - 1 Jan 2006
Externally publishedYes

Keywords

  • Cutaneous paraneoplastic syndrome
  • Mantle cell lymphoma
  • Rituximab
  • Wells' syndrome

Fingerprint

Dive into the research topics of 'Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: Favorable response to rituximab'. Together they form a unique fingerprint.

Cite this